about us
Marshall Edwards is a San Diego-based oncology company focused on the clinical development of novel cancer therapeutics.
[ Read more ]
our programs
Our lead programs focus on two families of compounds that target the inhibition of tumor cell metabolism, a critical function for cancer cells.
[ Read more ]
latest news
Marshall Edwards Issued New Patent for Lead Oncology Drug Candidate ME-344
[ January 3, 2012 ]
Marshall Edwards Adds $2 Million in Private Placement
[ December 29, 2011 ]
Marshall Edwards Awarded Key Patent for Compositions of Lead Oncology Drug Candidates
[ December 20, 2011 ]